10:01 AM EST - DRI Healthcare Trust : Announces that its wholly-owned subsidiary has sold its royalty interest and milestone payment obligations in the worldwide sales of TZIELD™ to a subsidiary of Sanofi S.A. for US$210 million. DRI Healthcare Trust
shares T.DHT.UN are trading up $1.72 at $9.65.
